MDX-2001

N/A

Report date: 2026/03/19 17:15:13

Base Information

Drug NameMDX-2001
Drug Alias NameMDX2001MDX-2001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Tetraspecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Hepatocyte growth factor receptorAnti-Trop-2Anti-CD3 +[4] 
TargetsHepatocyte growth factor receptorTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3 +[4] 
Therapy Area/IndicationsKidney NeoplasmsProstatic NeoplasmsUterine Cervical Neoplasms +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesModeX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesModeX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsKidney NeoplasmsProstatic NeoplasmsUterine Cervical Neoplasms +[15] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A